Navigation Links
Xmark Comments on Genaera Cost-Saving Plan
Date:5/9/2008

RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by Genaera Corporation (Nasdaq: GENR) on May 8, 2008 with respect to executive base compensation, cash incentives to executives, workforce reduction and the streamlining of expenditures.

"Management has made difficult, fiscally-responsible choices that will afford its shareholders the opportunity to profit from MSI-1436 and MEDI-528 without suffering dilution during a turbulent period in the markets," said Mitchell D. Kaye, the Chief Executive Officer of Xmark Opportunity Partners. Mr. Kaye added that, "this type of responsible behavior should serve as a model for similarly-situated companies in the small-cap biotech sector." Mr. Kaye is a member of the Board of Directors of Genaera.


'/>"/>
SOURCE Xmark Opportunity Partners, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
2. FRC Action Praises John McCains Pro-Life Comments
3. JAMA editor-in-chief comments on Pfizer lawsuit
4. Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography
5. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
6. MGT Comments on American Cancer Societys Decision to Endorse CT Colonography
7. URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
8. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
9. Boston Scientific Comments on New England Journal of Medicine Article
10. URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs
11. American College of Surgeons Comments on JAMA Article on Surgeon Shortage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 06, 2016 , ... For many years, Andrew G. Zubinas has ... The beauty of the Lithuanian language and its poetry inspired him in ... Zubinas lyrically explores all aspects of a living, breathing forest where nothing ever stays ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
(Date:12/5/2016)... Reading, PA (PRWEB) , ... December 05, 2016 , ... ... partner in the United States and Canada for distribution of their natural fruits ... Hansen colors line is an exciting addition to our Life Sciences product portfolio,” ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... was previously a subsidiary of Chiltern International and focuses on clinical trial ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... The new ... the individual looking to buy neoprene knee sleeves for lifting and any ... design focuses heavily on two main aspects to provide a higher quality knee sleeve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Eisai Inc. announced today new analyses and ... of the American Epilepsy Society (AES). ... adjunctive therapy for the treatment of partial onset seizures ... generalized tonic-clonic seizures (PGTC) in patients with epilepsy who ... Important Safety Information for FYCOMPA, including Boxed WARNING for ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... and Pregnancy Rapid Test Market Size, Share, Development, Growth and Demand ... ... The global female fertility and pregnancy rapid test market is ... global Female fertility and pregnancy rapid test market is witnessing high ...
(Date:12/5/2016)... AVIV, Israel , December 5, 2016 ... to identifying, in-licensing and developing promising therapeutic candidates, presents positive ... for BL-8040, the Company,s leading oncology platform at the ongoing ... in San Diego, California . ... , , ...
Breaking Medicine Technology: